Faculty

Sascha Dublin

Affiliate Professor, Epidemiology

206-287-2870

Education

PhD Epidemiology, University of Washington, 1999
MD University of Washington, 2001

Contact

206-287-2870

Kaiser Permanente Washington Health Research Institute
1730 Minor Avenue, Suite 1600
Seattle, WA 98101

Research Interests

Dr. Dublin’s research interests include pharmacoepidemiology, pregnancy outcomes and perinatal epidemiology; aging; and cardiovascular epidemiology. Her work uses real-world health care data from Group Health and many other sources to better understand the safety and effectiveness of medications and other medical interventions.  She often focuses on the impact of interventions in vulnerable populations, particularly pregnant women and older adults. She also has interest and expertise in using novel statistical and epidemiologic methods to answer real-world questions, such as the use of two-phase study designs to reduce bias and Natural Language Processing  to extract information from electronic medical records (EMRs).  She is the Group Health site Principal Investigator for the Medication Exposures in Pregnancy Risk Evaluation Program (MEPREP), a multisite collaboration that has developed data sets including 1.2 million pregnancies across 11 health plans to examine medication safety in pregnant women.

Recent Publications (PubMed)

The use of conjugated estrogens and bazedoxifene for the management of vasomotor symptoms in premenopausal and menopausal patients with endometriosis: a systematic review.
(2026 Jun 8)
Climacteric
Mejia-Gomez JC, Shprits E, Sosea C, Leslie B, Mathur S, Farooqi S, Chaudhry A, Bacal V, Essalah A, Shaltout N, Shea A, Sermer C, Hojabri S, Wolfman W, Stancati N, Jacobson M

Carbon footprint of single-use surgical drapes in an Irish gynecology service.
(2026 Jun 8)
Int J Gynaecol Obstet
Waters I, Nordrum OL, Burke C

Histological activity predicts relapse in pediatric ulcerative colitis despite mucosal healing: a multicenter study from the pediatric IBD Porto group of ESPGHAN.
(2026 Jun 7)
J Crohns Colitis 20(6):
Trivić Mažuranić I, Aloi M, Bramuzzo M, Chiantese C, D'Arcangelo G, Gattenlöhner S, Gianolio L, Granot M, Hızarcıoğlu Gülşen H, Hussey S, Kang B, Kolho KL, de Laffolie J, Lega S, Martinelli M, Matar M, Mayer C, Miele E, Norsa L, Panarese I, Rinawi F, Rohani P, Romano C, Sansotta N, Scarallo L, Shouval DS, Staiano A, Strisciuglio C, Tomas D, Yerushalmy-Feler A, Zojaji R, Hojsak I

Management of a Patient With Polypharmacy Toxicity (Calcium Channel Blocker, Angiotensin Converting Enzyme Inhibitor and Tricyclic Antidepressant) in Intensive Care Settings: A Case Report.
(2026)
Case Rep Anesthesiol 2026(): 8424003
Rehman SU, Zahid F, Nazim S, Cody C, Sweeney T

Superficial parasternal intercostal plane block with ropivacaine versus placebo for opioid exposure after cardiac surgery (EPOCH CardioLink-10): a multicentre, double-blind, randomised trial.
(2026 Aug)
Lancet Reg Health Am 60(): 101508
Alli A, Mazer CD, Dennis F, Teoh H, Chin K, Quan A, Hassan SMA, Szarek M, Tran JD, Dhingra NK, Ghiringhelli JP, de Vasconcelos Papa F, Lee Y, Ricci MJ, Verma R, Derry KL, George T, Krishnaraj A, Hess DA, Rotstein OD, Cook RC, Hassan A, Yau TM, Spence JD, Martinka PM, Sutherland K, Gregory AJ, Noss CD, de Jager P, Dougherty JL, Arora RC, Verma S

Show complete publication list

In the News